April 1, 2026 · Form 4 insider transaction
Bernstein Harold bought 15,000 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $156.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.